Metabolic complications are common in patients suffering PCOS, including obesity, insulin resistance and type-2 diabetes, which severely compromise the clinical course of affected women
In the first nine months of 2023, 3.2% of Massachusetts commercial members were prescribed a GLP-1 drug, a seven-fold increase from 2018, when 0.5% of members were prescribed one of these medications
Most concerns regarding kidney damage are linked to extremely high-dose intravenous injections used for non-wellness purposes, such as skin whitening, rather than nutritional supplementation
It could mean the difference between still qualifying as obese and reaching the overweight category
Tirzepatide also targets glucose-dependent insulinotropic polypeptide (GIP) receptors
Biologics, which are cutting-edge recombinant protein-based large-molecule drugs, have transformed the treatment of many complex and non-genetic diseases, including autoimmune disorders, cancers, and chronic inflammatory conditions